VC

Vivo Capital Portfolio holdings

AUM $977M
This Quarter Return
-15.52%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$783M
AUM Growth
+$783M
Cap. Flow
+$936K
Cap. Flow %
0.12%
Top 10 Hldgs %
67.03%
Holding
48
New
4
Increased
3
Reduced
8
Closed
3

Top Buys

1
IOVA icon
Iovance Biotherapeutics
IOVA
$14.2M
2
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
$12.8M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$10.7M
4
DBVT
DBV Technologies
DBVT
$1.73M
5
GLMD icon
Galmed Pharmaceuticals
GLMD
$819K

Top Sells

1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8.73M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$8.23M
3
APLS icon
Apellis Pharmaceuticals
APLS
$6.33M
4
TCDA
Tricida, Inc. Common Stock
TCDA
$4.96M
5
SBBP
Strongbridge Biopharma plc.
SBBP
$4.45M

Sector Composition

1 Healthcare 97.51%
2 Materials 2.38%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ASND icon
1
Ascendis Pharma
ASND
$11.8B
$136M 17.34% 2,166,832 – –
CRNX icon
2
Crinetics Pharmaceuticals
CRNX
$2.92B
$114M 14.52% 3,792,169 – –
BHVN
3
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$67.1M 8.56% 1,813,340 -236,205 -12% -$8.73M
CDXS icon
4
Codexis
CDXS
$246M
$45.3M 5.79% 2,714,458 -34,885 -1% -$583K
SVA
5
DELISTED
Sinovac Biotech, Ltd
SVA
$40.9M 5.23% 5,900,000 – –
ARWR icon
6
Arrowhead Research
ARWR
$3.05B
$28.9M 3.69% 2,328,475 – –
KALV icon
7
KalVista Pharmaceuticals
KALV
$678M
$26.8M 3.43% 1,359,149 – –
QTTB icon
8
Q32 Bio
QTTB
$20.9M
$25.9M 3.31% 1,159,742 – –
KDMN
9
DELISTED
Kadmon Holdings, Inc.
KDMN
$21.7M 2.78% 10,454,545 – –
AMRS
10
DELISTED
Amyris Inc.
AMRS
$18.6M 2.38% 5,575,785 +667 +0% +$2.23K
TCDA
11
DELISTED
Tricida, Inc. Common Stock
TCDA
$18.4M 2.35% 781,185 -210,526 -21% -$4.96M
EIGR
12
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$18.2M 2.32% 1,791,257 – –
VYNE icon
13
VYNE Therapeutics
VYNE
$8.16M
$16.5M 2.11% 4,011,236 – –
MEIP icon
14
MEI Pharma
MEIP
$160M
$15.3M 1.95% 5,778,106 – –
IOVA icon
15
Iovance Biotherapeutics
IOVA
$807M
$14.2M 1.81% +1,600,000 New +$14.2M
VRNA
16
Verona Pharma
VRNA
$9.16B
$13.4M 1.72% 1,492,951 – –
ORTX
17
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$12.8M 1.63% +811,894 New +$12.8M
ACRS icon
18
Aclaris Therapeutics
ACRS
$209M
$12.2M 1.55% 1,647,214 – –
OBSV
19
DELISTED
ObsEva SA Ordinary Shares
OBSV
$11.9M 1.52% 937,147 – –
ACER
20
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
$11.7M 1.49% 579,051 +13,472 +2% +$271K
APLS icon
21
Apellis Pharmaceuticals
APLS
$3.48B
$11.5M 1.47% 874,573 -479,981 -35% -$6.33M
MRTX
22
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$10.7M 1.36% +251,107 New +$10.7M
NBRV
23
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$9.66M 1.23% 6,619,190 – –
ZYME icon
24
Zymeworks
ZYME
$1.12B
$9.1M 1.16% 620,134 – –
XENE icon
25
Xenon Pharmaceuticals
XENE
$2.98B
$8.87M 1.13% 1,405,476 – –
1
2